An enhanced appreciation of uptake mechanisms and intracellular trafficking of phosphorothioate modified oligodeoxynucleotides (P-ODN) might facilitate the use of these compounds for experimental and therapeutic purposes. We addressed these issues by identifying cell surface proteins with which P-ODN specifically interact, studying P-ODN internalization mechanisms, and by tracking internalized P-ODN through the cell using immunochemical and ultrastructural techniques. 
Introduction
An enhanced appreciation of uptake mechanisms and intracellular trafficking of phosphorothioate modified oligodeoxynucleotides (P-ODN) might facilitate the use of these compounds for experimental and therapeutic purposes. We addressed these issues by identifying cell surface proteins with which P-ODN specifically interact, studying P-ODN internalization mechanisms, and by tracking internalized P-ODN through the cell using immunochemical and ultrastructural techniques. Chemical cross-linking studies with a biotin-labeled P-ODN (bPODN), revealed the existence of five major cell surface P-ODN binding protein groups ranging in size from -20-143 kD. Binding to these proteins was competitively inhibited with unlabeled P-ODN, but not free biotin, suggesting specificity of the interactions. Additional experiments suggested that binding proteins likely exist as single chain structures, and that carbohydrate moieties may play a role in P-ODN binding. Uptake studies with 35S-labeled P-ODN revealed that endocytosis, mediated by a receptor-like mechanism, predominated at P-ODN concentrations < 1 ,M, whereas fluid-phase endocytosis prevailed at higher concentrations. Cell fractionation and ultrastructural analysis demonstrated the presence of ODN in clathrin coated pits, and in vesicular structures consistent with endosomes and lysosomes. Labeled ODN were also found in significant amounts in the nucleus, while none was associated with ribosomes, or ribosomes associated with rough endoplasmic reticulum (ER). Since nuclear uptake was not blocked by wheat germ agglutinin or concanavalin A, a nucleoporin independent, perhaps diffusion driven, import process is suggested. These data imply that antisense DNA may exert their effect in the nucleus. They also suggest rational ways to design ODN which might increase their efficiency. (J. Clin. Invest. 1995.95:1814-1823.) Key words: oligodeoxynucleotides -antisense DNA * gene therapy * receptors * nuclear import Antisense oligodeoxynucleotides (ODN)' have been widely employed to disrupt gene function in a diverse array of in vitro culture systems ( 1, 2) . To a more limited extent they have also been employed for in vivo experimentation (e.g., [3] [4] [5] [6] [7] . Quite recently, nuclease resistant phosphorothioate modified ODN (P-ODN) have also been used clinically to treat patients with acute and chronic leukemias (8, 9) . Human trials using ODN to treat genital warts and patients with AIDS are also ongoing (10) . These forays into the clinic have further enhanced speculation that the antisense strategy for disrupting gene function may prove a useful addition to the treatment of these and other disorders in the not too distant future (10, 11) . Nevertheless, inefficient cellular uptake of DNA and lack of a precise understanding of how and where antisense DNA perturbs gene expression imposes limits on the therapeutic and experimental usefulness of these compounds. We therefore sought to identify cell surface proteins with which P-ODN interact, investigate P-ODN internalization mechanisms and, by utilizing immunochemical and ultrastructural techniques, track internalized P-ODN through the cell to understand more completely where antisense molecules and their targets likely come into contact. The results of our studies suggest that there are numerous cell surface proteins which bind P-ODN in an apparently specific manner. Our studies also suggest uptake of bound DNA is concentration dependent with endocytosis mediated by a receptorlike mechanism predominating at low concentration (< 1 ILM) and fluid phase endocytosis becoming more prominent above this concentration. Finally, once internalized, P-ODN move from the endosomal compartment into the cytoplasm and thence into the nucleus. During this transit, no convincing evidence was found to suggest that ODN associated with rough endoplasmic reticulum or with free ribosomes. These data suggest that the "antisense effect" may well occur in the nucleus and may therefore prove useful in the design of more effective molecules. using a column and conditions optimized for phosphorothioates (13) . A 5 '-fluorescein labeled derivative was similarly synthesized and HPLC purified using 6-FAM amidite (Applied Biosystems, Foster City, CA) ( 14) . This material was 58.7% pure by capillary electrophoresis. The major contaminant (25.8%) of the fluorescein labeled DNA was unlabeled full-length P-ODN. 35S-labeled P-ODN 24-mer was synthesized and purified as described (15 Cells were washed in tissue culture medium at 40C to remove free P-ODN, homogenized, and then fractionated by centrifugation. In brief, the washed cell pellet was diluted in 6 ml of hypotonic homogenizing medium (50 mM MOPS, pH 7.4, 1 mM PMSF) and allowed to stand at 40C for 10 min to swell the cells. Cells thus treated were homogenized with 50 strokes in a glass dounce. The homogenized cell suspension was transferred to a polycarbonate tube, and diluted with 6 ml 0.5 M sucrose in 50 mM MOPS, pH 7.4, with 1 mM PMSF. The sample was mixed and an aliquot removed for scintillation counting. The remaining material was centrifuged at 50 g for 5 min to remove intact cells. The supernatant fraction containing the cell homogenate sub-fractions (SI ) was centrifuged again at 1,000 g for 10 min to remove nuclei. Radioactivity associated with the isolated nuclei was quantitated using a scintillation counter. The resulting supernatant (S2) was centrifuged at 16,000 g for 20 min to remove plasma membranes, mitochondria, endosomes, and lysosomes. Radioactivity in the pellet was counted, and the resulting supernatant (S3) was centrifuged again at 160,000 g for 60 min to pellet the microsomal fraction containing free ribosomes, and ribosomes associated with rough endoplasmic reticulum. Radioactivity associated with this pellet was also counted, as were counts in the final supernatant (S4) which was the equivalent of free cytosol.
Recovery of P-ODN at each step was compared to total cellular uptake of labeled material under each condition. This was determined by removing a small aliquot of cells immediately after incubation with the labeled P-ODN. The labeled cells were separated from unincorporated counts by sucrose gradient centrifugation. The cell pellet was resuspended in liquid scintillation cocktail in I N NaOH and counted in a liquid scintillation counter. Protein concentration was determined in each fraction by the method of Lowry et al. ( 18) .
Ultrastructural localization ofbiotinylated oligodeoxynucleotides in K562 cells. Two different techniques, pre-and post-embedding labeling, were used to ultrastructurally localize cell associated 6P-ODN. Visualization of P-ODN membrane binding protein complexes and the initial internalization process required pre-embedding labeling of bound bp_ ODN because of the low concentrations of the ligand used to demonstrate receptor mediated uptake. In these studies, K562 cells (2 x 10' cells/ml) suspended in RPMI 1640 with 2% bovine calf serum (GIBCO-BRL) were incubated in the presence or absence of 100 nM c-myb antisense 'P-ODN at 4°C for 30 min to saturate putative membrane receptors without allowing internalization. Cells incubated without bp_ ODN were used as controls for labeling specificity. Cells were then washed 2x and resuspended in PBS pH 7.4. The 'P-ODN were crosslinked to surface binding proteins using the membrane impermeable cross-linker bis (sulfosuccinimidyl) suberate (BS 3) (20 mg/ml) (Pierce, Rockford, IL). The reaction was quenched by washing the cells 3x with 50 mM TRIS/HCL in 150 mM NaCI. To label the crosslinked bp_ ODN, cells were incubated at 4°C for 1 h with 10 nm gold-labeled streptavidin (Zymed Laboratories, Inc., South San Francisco, CA). Thereafter, the cells were warmed to 37°C for 20 min to initiate uptake. The cells were diluted in PBS at 4°C, centrifuged at 500 g, and the resulting cell pellet fixed overnight in 2% glutaraldehyde in PBS. The specimens were washed in 0.1 M sodium cacodylate and post-fixed with 2% OS04 in 0.1 M sodium cacodylate buffer, pH 7.4, for 1 h at 4°C. The cells were stained en bloc with 2% uranyl acetate, dehydrated with ethanol (70-100%) and propylene oxide (100%) and embedded in Spurr resin (Electron Microscopy Sciences, Fort Washington, PA). Thin sections were cut, collected on copper grids, and stained with saturated alcoholic uranyl acetate and bismuth subnitrate.
Because studies designed to demonstrate subsequent intracellular processing used a higher 'P-ODN concentration and longer incubation times, post-embedding labeling was used to detect the ligand. K562 cells (2. Angeles, CA) with a molecular weight cut-off of 12,000-14,000. Aliquots were frozen in liquid nitrogen and stored at -80°C.
To investigate the effect of lectins on nuclear import of P-ODN, permeabilized cells were pre-incubated (20 were seen as well. Identical data were obtained when DSS was used as the cross-linker (data not shown).
The specificity of the cross-linking of surface proteins and bP-ODN was determined by the following two sets of experiments. First, binding studies were carried out in the presence of a 500-fold excess of nonbiotinylated DNA competitor. Crosslinking was then performed as described. As seen in Fig. 2 2, lane 3) . We also found that in the presence of a vast excess (2 x 106 fold) of d-Biotin, the intensity of the bands to which the bP-ODN bound remained unchanged except for the band at -22 kD, which disappeared (Fig. 2, lane 1) . Finally, we demonstrated that in the presence of excess of both d-biotin and P-ODN the bands remaining, if any, were identical to those observed in the presence of competing P-ODN alone (Fig. 2,  lane 2) . Therefore, except for the protein at 22 kD, P-ODN were shown to bind specifically to a large number of cell surface proteins.
Quantitation of P-ODN binding sites on K562 cells. We next sought to determine the actual number of P-ODN binding sites on the surface of K562 cells. Binding stdies and Scatchard plot analysis were performed as described ( 16) . 1 106 intact K562 cells were incubated with serial dilutions of 35S-labeled P-ODN (1 MCi/Mg, 2 x 106 dpm) in the presence or absence of 100-fold excess of unlabeled P-ODN competitor. After washing, cell associated (bound) and soluble (free) material was collected and the counts were determined. Results were plotted and subjected to Scatchard Analysis (Fig. 3) . The analysis suggested that the binding proteins, though numerous, were of a single binding affinity. The average affinity detected from 4 independent experiments was of 3.5+±2.2 ,uM, and there appeared to be approximately 200,000 binding sites/cell on the surface. All binding sites were competed by the addition of unlabeled P-ODN, suggesting that the putative receptors are indeed specific for P-ODN (Fig. 3) . Similar studies were carried out with two other leukemic cell lines, Jurkatt and EL-4. Though receptor density varied on these lines (from 2-5-fold in comparison to K562) P-ODN receptor affinity was not significantly different (HUS, data not shown). Finally, we also examined binding of higher molecular weight native DNA fragments (X digest, 1-12 kB) to determine if larger DNA fragments were bound to cells by a different class of proteins. We found however that the apparent number and affinity of receptors for high molecular weight DNA fragments was indistinguishable from those which bound the P-ODN (HUS, data not shown).
Direct detection and partial characterization of P-ODN binding proteins. , and then isolated by affinity precipitation with Avidin-Sepharose. After isolation, complexes formed with DSP were dissociated by cleavage of the crosslinker by subjecting it to DTT reduction. Proteins obtained by both cross-linking methods were resolved by SDS-PAGE and bands were detected by autoradiography. The intensity of bands detected by this method of labeling was clearly less than obtained by cross-linking to the bp_ ODN. Nevertheless, we were still able to demonstrate that the size and number of P-ODN PBs was identical regardless of whether the non-cleavable or cleavable cross-linker was used (Fig. 4) . Accordingly, the bands resolved in Fig. 2 (-20 kD) suggesting that this interaction was primarily charge mediated. Visualization ofP-ODN uptake and intracellular trafficking. The data presented above suggested that P-ODN were taken into cells by fluid phase endocytosis and by receptor-mediated endocytosis. The latter mechanism would predict the existence of proteins which specifically bound the P-ODN, and this was ultimately verified. We then undertook experiments to directly visualize the uptake process and to track the P-ODN once they had entered the cell (Fig. 6) . Endocytosis is accomplished in many cells by the formation of coated pits and vesicles. Accordingly, we would predict that labeled material would be detected within such structures. Using a pre-embedding technique and gold-tagged bPODN we were able to directly visualize oligodeoxynucleotides within clathrin coated pits on the cell surface of K562 cells (Fig. 6 A) . To track internalized oligodeoxynucleotides, we used a post-embedding technique and were able to show P-ODN within clear vesicles. Such structures are likely coated vesicles which have lost their clathrin coat, consistent with transport within endosomes (Fig. 6 B) . Besides being located within or at the periphery of endosomes, P-ODN can be seen within dense, lysosome-like structures (Fig. 6 C) . In other sections, P-ODN were also visualized free within the cytoplasm and within the nucleus. In the latter structure they prefer- T h a i w r S ¢ 4 t 4 .
w K eon jj=.,: e X X >, An 4. S mu @;^4< 4 I Z P r e n -A E g ; t i l S s a w -. . 1 n . . . -. . 4 ; v H e A n d . E S a c e S < . entially localized to the euchromatin/heterochromatin interface (Fig. 6 D) . Cells incubated with avidin-gold in the absence of bPODN showed only a few, randomly distributed gold particles (Fig. 6 E) . We were also very interested in knowing if labeled P-ODN could be detected in the endoplasmic reticulum or in association with ribosomes. Since it has been suggested that ODN may perturb gene function by hybridizing with mRNA and preventing ribosomal translation, such an association might reasonably be expected. Nevertheless, an extensive search of the ultrastructural data available failed to reveal an association between these structures and the labeled P-ODN. To substantiate the observation that P-ODN do not associate appreciably with ribosomes or endoplasmic reticulum, cell fractionation studies were carried out after incubating K562 cells with 35S-labeled P-ODN.
As shown in Table I , the major site of P-ODN accumulation was the nucleus. The specific activity of P-ODN binding to the nuclear fraction was 3740 pmole/mg of protein (-50% of total) after 60 min incubation at 370C. The only other significant site of P-ODN accumulation was the plasma membrane where 755 pmole/mg of protein was detected. In contrast, 92 pmole/ mg protein accumulated in the microsomal fraction containing the ribosomes. The latter value represented 2% of the nuclear specific activity and could not be reliably distinguished from background counts. It is therefore unlikely that there is a significant association between P-ODN and mRNA translational machinery in the cytoplasm.
Mechanism ofnuclear import ofP-ODN. To investigate the mechanism of nuclear import of P-ODN we established a system similar to those utilized to study nuclear import of proteins. This system employs an agent, digitonin, which selectively permeabilizes the cell's cytoplasmic membrane while leaving the cytoskeleton and the nucleus intact. When incubated in the appropriate medium, cells remain viable for several hours. It is therefore preferable to systems which utilize physical isolation techniques since they invariably result in damage to the nucleus and supporting structure.
To test this system, HS 294 T melanoma cells were cultured for 48 h, permeabilized with digitonin, and then incubated with either anti-vimentin mouse IgG or anti-PCNA mouse IgG as described in the methods. After washing, and addition of FITC labeled rabbit anti-mouse IgG, the cells were analyzed by phase contrast and fluorescence. In the majority of digitonin-treated HS 294 T cells the cell membrane became permeabilized to molecules the size of IgG as demonstrated by the detection of the cytoskeletal protein vimentin with anti-vimentin (Fig. 7, A  and B) . Integrity of the nuclear envelope in the digitonin-treated cells was demonstrated by showing that, in the absence of nuclear permeabilizing agents, incubating cells with an anti-PCNA antibody produced no fluorescence signal (Fig. 7, C and D) . In contrast, following permeabilization of the nuclear envelope with methanol and triton, the same antibody gave easily detectable signal in the nucleus of the cells (Fig. 7, E and F) . Since this system performed as expected, we then utilized it to examine potential nuclear uptake mechanisms of P-ODN.
To determine whether P-ODN uptake used nuclear pore transport mechanisms similar to those employed for transport of larger proteins, t-RNAs, and snRNPs we investigated whether nuclear import could be blocked by either wheat germ agglutinin (WGA) or concanavalin A (Con A). Digitonin-treated HS 294 T cells were first exposed to fluorescein labeled P-ODN. In the absence of cytoplasmic and nuclear permeabilization, no labeled ODN was detectable in the nucleus of the digitonin treated cells (Fig. 8, A and B) . Nuclear fluorescence was clearly visible however after treating cells with digitonin and triton indicating that the labeled P-ODN could enter the nuclei (Fig.  8 , C and D). When digitonin treated cells were exposed to the fluorescein labeled P-ODN after pre-treating cells with either WGA (Fig. 8, E and F) or CON-A (Fig. 8 , G and H) nuclear fluorescence was clearly seen. These experiments suggest that nuclear uptake of the P-ODN does not rely on nucleoporins since transport dependent on these proteins is consistently blocked by lectins like WGA and Con-A.
Discussion
It was once assumed that highly charged DNA molecules could not be transported across cell membranes. This widely held belief has now been shown to be erroneous, as many laboratories have provided evidence that DNA molecules, of both low and high molecular weight, can associate with cell surfaces and become internalized (21-26). There has been recent speculation that the ability to internalize DNA may represent a salvage pathway for material excreted by apoptotic cells (27) , however the physiologic significance of DNA import remains uncertain. Equally uncertain is the mechanism whereby these molecules are taken into cells. Renewed interest in this subject has been prompted by reports that uptake of naked DNA may provide a vehicle for delivery of some forms of gene therapy ( 1, 10, 11) . Accordingly, we sought to better define both uptake mechanisms and intracellular trafficking of phosphorothioate modified DNA molecules since these are presently being evaluated in a number of clinical settings. In contrast to earlier studies, we simultaneously employed both biochemical and ultrastructure visualization techniques. We also used P-ODN that had been labeled with biotin, a molecule not previously utilized for this purpose. We labeled the P-ODN with biotin for several reasons. First, the N-groups in the uriedo ring of the biotin-moiety enabled the formation of stable cross-links between the P-ODN and the proteins to which they had bound. Second, the biotin moiety also permitted sensitive, specific, and rapid colorimetric detection of the P-ODN binding proteins complexes. Lastly, the biotin molecule provided a means of visualizing P-ODN binding, internalization, and intracellular trafficking at the ultrastructural level by electron microscopy using streptavidin-gold particles. The validity of this approach was of course dependent on demonstrating that the biotin moiety itself was not contributing to the observations being made. This was a concern since it is known that free biotin is taken up by some cells in a concentration (28) and energy dependent manner (29) . It is also known that complexing biotin to other molecules, for example avidin (29) (30) (31) (Fig. 2) , and that biotin molecules existent within cells were not significantly labeled by the avidingold particles used to detect the bP-ODN by EM.
At present, controversy exists as to whether uptake of P-ODN relies on fluid phase endocytosis, receptor mediated endocytosis, or both. Evidence supporting each of these mechanisms has recently been reviewed by Bennet (27) . In essence however, it has been shown that uptake of either native or modified ODN molecules is saturable, subject to competition, and is energy and temperature dependent (26, 32). Energy and temperature dependence indicate only that the process is active, since either fluid phase endocytosis and receptor mediated endocytosis will both be effected by changes in these parameters. That ODN uptake is saturable, and subject to specific competitive inhibition suggests a receptor mediated process, but evidence indicating that ODN are taken up by a protein kinase C-dependent pinocytotic mechanism has also been provided (25) . Our studies appear to resolve some of these issues by demonstrating that below a concentration of 1 yM, P-ODN uptake is predominantly via a receptor-like mechanism while at higher concentrations, a fluid phase endocytosis mechanism appears to predominate. These studies therefore support earlier work which suggested that ODN uptake mechanisms are likely to vary with extracellular concentration (21) and extend them by providing the first direct physical evidence that ODN may be found within clathrin coated pits on the cytoplasmic membrane.
The presence of P-ODN in clathrin coated pits per se does not distinguish between a fluid phase or a receptor-like endocytotic import mechanisms. Nevertheless, we believe that we have visualized the latter for several reasons. First, P-ODN binding was carried out at 4°C. The cells were then washed at this temperature prior to cross linking the membrane bound material. Given the low affinity nature of the P-ODN binding protein interactions, it is unlikely that significant material would have remained associated with the membrane for endocytosis to occur when the cells were subsequently warmed to 37°C. Second, the competition and binding experiments also indicate the pres- Once internalized, P-ODN traffic through the endosomallysosomal pathway. This was demonstrated in two ways. Subcellular fractionation showed accumulation of 35S-labeled P-ODN in vesicular structures and in the nucleus but significantly less in the cytoplasm. This is consistent with sequestering of P-ODN in the endosomal-lysosomal compartment and nuclear translocation upon release from the vesicles. This flow was confirmed by our electron microscope studies. To our knowledge, these studies represent the first time that intracellular trafficking of P-ODN has been visualized at the ultrastructural level. In fact, we are aware of only one other study which attempted to track ODN through cells at the electron microscope level (36) and it differed in important aspects from the studies which form the basis of this report. Whereas the earlier study employed tritium labeled phosphodiester ODN which are potentially subject to rapid degradation in the intracellular milieu, we utilized stable P-ODN. In addition, though the authors hypothesized that ODN were taken up by cells either by "potocytosis," or through caveolae they did not demonstrate ODN in surface pits or within cytoplasmic vesicles. In contrast, our data now provide direct evidence to support the hypothesis that receptor mediated endocytosis is a mechanism for importing P-ODN into cells. Unfortunately, the relative contribution of each is difficult to determine since once the P-ODN are within endosomes it is impossible to distinguish between the two mechanisms.
A potentially important implication of our studies derives from detecting labeled ODN at the heterochromatin-euchromatin border and our inability to detect P-ODN in association with ribosomes or endoplasmic reticulum, either at the ultrastructural level or in the complementary sub-cellular fractionation studies with 35S-labeled material. Association of P-ODN with ribosomes or endoplasmic reticulum would be anticipated if P-ODN were inhibiting mRNA translation at the cytoplasmic level. Since no apparent relationship between ODN and ribosomes was uncovered, these results provide direct physical evidence to support the hypothesis that antisense DNA molecules exert their effects in the nucleus, perhaps through the formation of mRNA-DNA duplexes or by interfering with transcription, processing, or transport of the target mRNA. The mechanism whereby P-ODN gain access to the nucleus therefore becomes a critical issue. Nuclear import of fluorescein-labeled P-ODN in digitonin permeabilized cells was not inhibited by WGA or Con A. This argues against P-ODN being transported into the nucleus by a mechanism analogous to the one utilized by snRNPs since nuclear transport of these protein nucleotide complexes is lectin inhibitable (37, 38) . This result is also inconsistent with P-ODN using karyophilic cytoplasmic proteins as a shuttle for nuclear import since one would expect to inhibit such a process with WGA. Rather, our results suggest that P-ODN transverse the nuclear pores by passive diffusion. The FITC-labeled c-myb P-ODN is assumed to be a random coil between 180-230 A long, [15] [16] [17] [18] A wide, and with a molecular weight of 8500 (DeDionisio, personal communication). It is therefore small enough to pass through nuclear pores by passive diffusion. These studies support the conclusion of Clarenc et al who studied nuclear import of ODN into isolated nuclei or microinjected cells and suggested that the process was energy and temperature independent and therefore likely to proceed by diffusion (39) .
The work reported herein both confirms and extends the work of many laboratories which have been interested in the cellular handling of oligodeoxynucleotides. By employing methods not previously utilized to address this issue we have generated novel, and potentially useful information for the design of newer and hopefully more efficient antisense ODNs. Our work predicts that ODN with nuclear localization signals may be highly efficient. However, it must be anticipated that modifications designed to increase nuclear uptake might also lead to decreased bioavailability. This (26, 39, 40) . Alternatively, modifications designed to prevent nuclear import might also have favorable qualities since such molecules would likely reach higher cytoplasmic concentrations, and should therefore have a greater chance of associating with ribosomal mRNA. This of course presumes that molecules with the desired modifications will be released intact from the vesicles in which they were imported. Accordingly, strategies aimed at increasing release of ODN from endosomal structures (41) may also be successful for similar reasons. Certainly, much remains to be learned about these compounds and their mechanism(s) of action. Studies such as the ones which form the basis of this report will hopefully contribute to this process and the further development of the molecules into useful pharmaceutical agents.
